INCREASING ASTHMA INCIDENCE, TREATMENT, PACES 8% ASTHMA/ALLERGY MARKET GROWTH.MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--The combined U.S. market for allergy and asthma treatments will grow from $3.1 billion in 1993 to $5.4 billion by the year 2000 at an 8 percent compound annual rate, projects a new study just released by Frost & Sullivan. Asthma drugs and devices will increase their share of market revenues from 54 percent in 1993 to 57 percent by 2000 as both the number of asthma cases rises and physicians increasingly prescribe multiple lines of treatment, while other allergy therapeutics correspondingly dip slightly in share from 43 to 41 percent in the same period, forecasts the report, U.S. ALLERGY AND ASTHMA TREATMENT MARKETS: NEW GENERATION OF PRODUCTS OFFER GROWTH OPPORTUNITIES -- AN ONGOING ASSESSMENT. Some 15 million Americans now have asthma, with that number swelling by 10 percent annually. The share of allergy non-asthma market revenues going to nasal inhalants inhalants, n.pl 1. chemical vapors that are inhaled for their mind-altering effects. 2. in herbology, volatile herbal compounds that are delivered by holding a soaked pad to the nose and mouth, by placing the herbs in steaming water, or will rise from 27 percent in 1993 to 39 percent in 2000 and that of ophthalmic anti-allergy medications from 2 to 5 percent in the same period while "single-entity" antihistamines Antihistamines Definition Antihistamines are drugs that block the action of histamine (a compound released in allergic inflammatory reactions) at the H1 dip in share from 46 percent in 1993 to 37 percent in 2000, forecasts the report. New asthma drugs in development and projected for 1996 introduction have "blockbuster" potential. These leukotriene leukotriene /leu·ko·tri·ene/ (-tri´en) any of a group of biologically active compounds derived from arachidonic acid that function as regulators of allergic and inflammatory reactions. formation blockers stop the occurrence of asthma-causing inflammation at an earlier biochemical stage. Eleven drugs in eight different asthma and allergy segments are new on the market, including products that have already become, or may soon become, best-sellers in their categories. The product pipeline is also full, with some 20 compounds in nine segments currently in FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. review. Generic competition in the allergy and asthma markets will grow rapidly. Generics are now approaching half the total U.S. drug market and will grow well beyond this as cost-conscious administrators increasingly substitute them for higher-priced brands. Research-based drug firms will increasingly set up their own generic operations, enter licensing agreements with generic firms and buy into them. Cost control initiatives will dampen market growth prospects. Large cost-conscious organizations will be negotiating big discounts, forcing prices down and often limiting their physicians to options on a formulary formulary /for·mu·lary/ (for´mu-lar?e) a collection of recipes, formulas, and prescriptions. National Formulary see under N. for·mu·lar·y n. , a list that will typically contain the least costly drug that provides required clinical effects. New alternatives to metered dose inhaler inhaler /in·hal·er/ (in-hal´er) 1. an apparatus for administering vapor or volatilized medications by inhalation. 2. ventilator (2). in·hal·er n. formulations using CFC CFC See: Controlled foreign corporation (chlorofluorocarbon chlorofluorocarbon (CFC) Any of several organic compounds containing carbon, fluorine, and chlorine. A number of different CFCs have been made and sold under the trade name Freon. ) propellant pro·pel·lant also pro·pel·lent n. 1. Something, such as an explosive charge or a rocket fuel, that propels or provides thrust. 2. are being developed for asthma as a result of international agreements to stop CFC use to limit destruction of the atmospheric ozone layer. Leading alternatives include dry powder inhalers (DPI (Dots Per Inch) The measurement of the resolution of display and printing systems. A typical CRT screen provides 96 dpi, which provides 9,216 dots per square inch (96x96). Flat panel displays from 110 to 200 dpi have also been developed. ) that require no propellant, some of which are already available in European markets. Other firms are working on CFC-free metered dose inhalers using hydrofluorocarbons hydrofluorocarbons: see under chlorofluorocarbons. (HFCs) as an alternative propellant. The CFC ban will cause metered dose inhaler formulations to rise in price. New approaches to immunotherapy currently in clinical testing claim to be safer, faster and more effective than traditional immunotherapy. This study is produced as part of Frost & Sullivan's business planning series and is updated on a quarterly basis. Frost & Sullivan is an international high-technology research firm. All Frost & Sullivan reports are based on extensive interviews with marketing and technical experts from selected companies in each market segment. Primary research is validated by thorough analysis of available secondary research. Frost & Sullivan is the leading publisher worldwide of high-technology research reports. Report: 5201-52 Publication Date: 1994 Price: $3295 Total Allergy and Asthma Treatment Markets: Revenue Forecasts (U.S.), 1990-20003-1 Total Allergy and Asthma Treatment Markets: Revenue Forecasts (U.S.), 1990-2000gures Revenue RevenuesGrowth Rate Year ($ Billion) (%) 1990 2.40 --- 1991 2.75 14.7 1992 3.00 7.3 1993 3.09 4.4 1994 3.35 8.5 1995 3.64 8.7 1996 3.95 8.5 1997 4.28 8.4 1998 4.63 8.2 1999 5.00 8.0 2000 5.39 7.8 Compound Annual Growth Rate (1993-2000): 8.3% Note: All figures are rounded. Source: Frost & Sullivan CONTACT: For further information please contact: Amy Arnell Kristina Menzefricke Nadge Keryhuel Mountain View London Paris (415) 961-9000 44 171 730 3438 33 1 4742 9127 (415) 961-5042(fax) 44 171 730 3343 33 1 4742 9129 REPEATS: New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of 212-575-8822 or 800-221-2462; Boston 617-330-5311 or 80 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion